TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine
Link
http://link.springer.com/content/pdf/10.1007/s12253-020-00829-9.pdf
Reference62 articles.
1. Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65(1):5–29
2. Raffone A, Travaglino A, Mascolo M, Carbone L, Guida M, Insabato L, Zullo F (2019) TCGA molecular groups of endometrial cancer: pooled data about prognosis. Gynecol Oncol 155(2):374–383
3. Travaglino A, Raffone A, Saccone G, de Luca C, Mollo A, Mascolo M, de Placido G, Insabato L, Zullo F (2019) Immunohistochemical nuclear expression of β-catenin as a surrogate of CTNNB1 exon 3 mutation in endometrial Cancer. Am J Clin Pathol 151(5):529–538
4. Raffone A, Travaglino A, Santoro A, Esposito I, Angelico G, Spadola S, Zannoni GF (2019) Accuracy of one-step nucleic acid amplification in detecting lymph node metastases in endometrial cancer. Pathol Oncol Res. https://doi.org/10.1007/s12253-019-00727-9
5. Travaglino A, Raffone A, Saccone G, Insabato L, Mollo A, de Placido G, Zullo F (2019) Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: a systematic review. Acta Obstet Gynecol Scand 98:1086–1099. https://doi.org/10.1111/aogs.13587
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. New clinicopathological concept of endometrial carcinoma with integration of histological features and molecular profiles;Pathology International;2024-08-22
2. Endometriumkarzinom: molekulare Klassifikation in der Routinepathologie;Die Pathologie;2024-08-14
3. An uncommon case of POLE mutated uterine carcinosarcoma − complemented by a review of literature;Gynecologic Oncology Reports;2024-08
4. MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy;Annals of Oncology;2024-07
5. Landscape of Endometrial Cancer: Molecular Mechanisms, Biomarkers, and Target Therapy;Cancers;2024-05-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3